US CDC guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) – 2012 CRE toolkitArchived
Carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae (CPE) are highly resistant to antibiotics, leaving only a few options for treatment of infected patients, and thus represent a serious threat to public health.
US CDC report on antibiotic resistance threats in the United States, 2013
Antimicrobial resistance represent a serious threat to public health and patient safety and is a worldwide problem. Each year, in the European Union (EU) at least 25 000 patients die of infections with multidrug-resistant bacteria.
Collection of online resources for prevention and control of antimicrobial resistance and healthcare-associated infections now available
ECDC gathered guidance documents on prevention and control of infection with carbapenem-resistant Enterobacteriaceae (CRE) available online, published by EU/EEA Member States, ECDC, other agencies and scientific societies.
Epidemiological update: invasive infections with Mycobacterium chimaera potentially associated with heater-cooler units used during cardiac surgery
On 21 May, Public Health England (PHE) reported that a retrospective investigation identified 13 patients with endocarditis, surgical site infection or disseminated infection with Mycobacterium chimaera or other Mycobacterium avium complex (MAC) species within four years of surgery involving cardiopulmorary bypass.
Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds – editorial in Eurosurveillance
The editorial published yesterday in Eurosurveillance highlights the current situation on the spread of plasmid-mediated colistin resistance gene (mcr-1). It also summarises available data from previously published articles and raises awareness about yet another threat to patient safety.
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Europe
The global rise of carbapenemase-producing Enterobacteriaceae (CPE) is alarming and is an increasing threat to patient safety, in Europe and globally.
Antimicrobial resistance remains high – says EU report
The findings in the latest report on antimicrobial resistance (AMR) in bacteria from ECDC and EFSA underline the serious threat AMR poses to public and animal health. Infections caused by bacteria that are resistant to antimicrobials lead to about 25 000 deaths in the EU every year.
Cross-border transfer increases patients’ risk of resistant bacteriaArchived
Patient transfer between hospitals and in particular between countries, is a risk factor for the spread of bacteria that are resistant to last-line antibiotics. More specifically, for highly resistant bacteria, like carbapenamase-producing Enterobacteriaceae (CPE), the risk is heightened when patients are transferred from, or have received previous medical care in areas with high rates of bacterial resistance. These are conclusions from a risk assessment produced by ECDC that evaluated the risk to the citizens of Europe, of the spread of CPE through patient transfer between healthcare facilities, with special emphasis on cross-border transfer.
ECDC releases new web pages on the Surveillance of Healthcare-associated InfectionsArchived
On the occasion of World Hand Hygiene Day, 5th May, ECDC is releasing new web pages dedicated to the Healthcare-associated Infections Surveillance Network (HAI-Net) – a European network for HAI surveillance, coordinated by ECDC.
ECDC experts on country visit to GreeceArchived
Following an invitation from Greek authorities, ECDC Director Marc Sprenger and experts from the ECDC Programmes for Sexually Transmitted Infections including HIV and blood-borne infections and Antimicrobial Resistance and Healthcare-associated Infections will visit Greece on 29 and 30 November 2012.